MRONJ Prevention Oral Bisphosphonates — NDEB AFK MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Perform the extraction atraumatically with primary closure and inform the patient of the small MRONJ risk
For patients on oral bisphosphonates, the MRONJ risk from dental extractions is low (approximately 0.01-0.04%). Current guidelines recommend informing the patient of the small risk, performing the extraction as atraumatically as possible, achieving primary soft tissue closure, and ensuring follow-up. Drug holidays are controversial and not uniformly recommended for dental procedures. Serum CTX is no longer considered a reliable predictor of MRONJ risk. The risk is higher with IV bisphosphonates (zoledronic acid) used for oncological indications.
Reference: CDA – MRONJ Position Statement, 2020; AAOMS – MRONJ Position Paper, 2022